Krish S. Krishnan, President and CEO at Krystal Biotech, Inc. (KRYS), sold 15,372 shares at $80.09 ($1.2M) on 2023-01-04, disclosed to the SEC on 2023-01-05.
Open-market sale of $1.2M KRYS by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.08 | 3,748 | $300K | 24.4% |
| 2 | $80.08 | 3,748 | $300K | 24.4% |
| 3 | $80.09 | 3,938 | $315K | 25.6% |
| 4 | $80.09 | 3,938 | $315K | 25.6% |
| Total | $80.09 avg | 15,372 | $1.2M | 100% |
| Filing → |
| KRYS | SELL | 2026-03-06 | $13.2M | — | Filing → |
| KRYS | SELL | 2025-12-05 | $20.9M | — | Filing → |
| KRYS | SELL | 2025-07-16 | $10.1M | — | Filing → |